Covariate-adaptive randomization represents an advanced methodology in the design of clinical trials, ensuring a balanced distribution of prognostic factors among treatment groups. This approach ...

"Time has stood still" for many who've been on complex regimens for decades ...

Immunocore (IMCR) announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous ...

For patients with complex chronic total occlusion (CTO) lesions undergoing bailout PCI, a two-stage intervention alongside a strategy of subintimal tracking and reentry (STAR) leads to good technical ...